Literature DB >> 25950198

Analysis of pulmonary surfactant in rat lungs after inhalation of nanomaterials: Fullerenes, nickel oxide and multi-walled carbon nanotubes.

Chikara Kadoya1, Byeong-Woo Lee1, Akira Ogami1, Takako Oyabu1, Ken-ichiro Nishi1, Makoto Yamamoto1, Motoi Todoroki1, Yasuo Morimoto1, Isamu Tanaka1, Toshihiko Myojo1.   

Abstract

The health risks of inhalation exposure to engineered nanomaterials in the workplace are a major concern in recent years, and hazard assessments of these materials are being conducted. The pulmonary surfactant of lung alveoli is the first biological entity to have contact with airborne nanomaterials in inhaled air. In this study, we retrospectively evaluated the pulmonary surfactant components of rat lungs after a 4-week inhalation exposure to three different nanomaterials: fullerenes, nickel oxide (NiO) nanoparticles and multi-walled carbon nanotubes (MWCNT), with similar levels of average aerosol concentration (0.13-0.37 mg/m(3)). Bronchoalveolar lavage fluid (BALF) of the rat lungs stored after previous inhalation studies was analyzed, focusing on total protein and the surfactant components, such as phospholipids and surfactant-specific SP-D (surfactant protein D) and the BALF surface tension, which is affected by SP-B and SP-C. Compared with a control group, significant changes in the BALF surface tension and the concentrations of phospholipids, total protein and SP-D were observed in rats exposed to NiO nanoparticles, but not in those exposed to fullerenes. Surface tension and the levels of surfactant phospholipids and proteins were also significantly different in rats exposed to MWCNTs. The concentrations of phospholipids, total protein and SP-D and BALF surface tension were correlated significantly with the polymorphonuclear neutrophil counts in the BALF. These results suggest that pulmonary surfactant components can be used as measures of lung inflammation.

Entities:  

Keywords:  C60; MWCNTs; SP-D; inhalation; phospholipid; pulmonary surfactant

Mesh:

Substances:

Year:  2015        PMID: 25950198     DOI: 10.3109/17435390.2015.1039093

Source DB:  PubMed          Journal:  Nanotoxicology        ISSN: 1743-5390            Impact factor:   5.913


  7 in total

Review 1.  The asbestos-carbon nanotube analogy: An update.

Authors:  Agnes B Kane; Robert H Hurt; Huajian Gao
Journal:  Toxicol Appl Pharmacol       Date:  2018-06-28       Impact factor: 4.219

2.  Brain-Derived Glia Maturation Factor β Participates in Lung Injury Induced by Acute Cerebral Ischemia by Increasing ROS in Endothelial Cells.

Authors:  Fei-Fei Xu; Zi-Bin Zhang; Yang-Yang Wang; Ting-Hua Wang
Journal:  Neurosci Bull       Date:  2018-09-06       Impact factor: 5.203

3.  Examination of Surfactant Protein D as a Biomarker for Evaluating Pulmonary Toxicity of Nanomaterials in Rat.

Authors:  Taisuke Tomonaga; Hiroto Izumi; Yukiko Yoshiura; Chinatsu Nishida; Kazuhiro Yatera; Yasuo Morimoto
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 4.  Review and Evaluation of the Potential Health Effects of Oxidic Nickel Nanoparticles.

Authors:  Sharlee L More; Michael Kovochich; Tara Lyons-Darden; Michael Taylor; Alexandra M Schulte; Amy K Madl
Journal:  Nanomaterials (Basel)       Date:  2021-03-05       Impact factor: 5.076

5.  Exposure to nickel oxide nanoparticles induces pulmonary inflammation through NLRP3 inflammasome activation in rats.

Authors:  Zhengwang Cao; Yiliang Fang; Yonghui Lu; Fenghua Qian; Qinglong Ma; Mingdi He; Huifeng Pi; Zhengping Yu; Zhou Zhou
Journal:  Int J Nanomedicine       Date:  2016-07-22

Review 6.  Interactions of particulate matter and pulmonary surfactant: Implications for human health.

Authors:  Feifei Wang; Jifang Liu; Hongbo Zeng
Journal:  Adv Colloid Interface Sci       Date:  2020-08-19       Impact factor: 12.984

7.  Changes over time in pulmonary inflammatory response in rat lungs after intratracheal instillation of nickel oxide nanoparticles.

Authors:  Ken-Ichiro Nishi; Chikara Kadoya; Akira Ogami; Takako Oyabu; Yasuo Morimoto; Susumu Ueno; Toshihiko Myojo
Journal:  J Occup Health       Date:  2020-01       Impact factor: 2.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.